Log in to search using one of your social media accounts:

 

Study shows vaccine confirmed to reduce and eradicate cervical cancer
The benefits of Gardasil are wildly debated across the United States by concerned parents, and the University of Alabama at Birmingham is paying attention. UAB's Comprehensive Cancer Center, along with a medical coalition of Alabama health groups, have made inroads into displaying Gardasil's effectiveness. According to a new study from the coalition, recent results confirm that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers. D r. Warner Huh, professor and director in the gynecologic… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 7, 2017 Category: Health Management Authors: Tyler Patchen Source Type: news

3 Scientists and Planned Parenthood Win Lasker Prizes for Medical Research
(NEW YORK) — Two scientists who paved the way for widely used vaccines and another who discovered key players in cell growth have been awarded prestigious medical research awards. The Albert and Mary Lasker Foundation also announced Wednesday that it was giving its public service award to Planned Parenthood. Each award includes a $250,000 honorarium. The foundation’s clinical research award is shared by Dr. Douglas Lowy and John Schiller of the U.S. National Cancer Institute. In the early 1990s they began work that would eventually lead to vaccines against human papillomavirus, or HPV, which causes cervical can...
Source: TIME.com: Top Science and Health Stories - September 6, 2017 Category: Consumer Health News Authors: Malcolm Ritter / AP Tags: Uncategorized awards medical research onetime Planned Parenthood Science Source Type: news

$1.8 million granted to YSPH to study effectiveness of HPV vaccine
A $1.8 million National Institutes of Health grant will help Yale researchers shed light on the real-world effectiveness of the Human Papillomavirus vaccine. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 5, 2017 Category: Universities & Medical Training Source Type: news

Vaccine to prevent most cervical cancers shows long-term effectiveness
This study of 14,215 women in 18 countries extends and solidifies the initial phase 3 efficacy and safety trial of the nine-valent human papilloma virus vaccine, Gardasil 9, that was published in February 2015 in The New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 5, 2017 Category: Cancer & Oncology Source Type: news

Vaccine makers rely on "statistical gimmicks" to obscure the truth about HPV vaccines harming children
(Natural News) It has been more than a decade since Gardasil, the first ever vaccine specifically intended to prevent cancer, was approved for use by the FDA. At the time, Gardasil was touted as a miracle shot that would prevent young girls from being infected with the human papillomavirus (HPV), which causes genital warts, as... (Source: NaturalNews.com)
Source: NaturalNews.com - August 24, 2017 Category: Consumer Health News Source Type: news

Gardasil or Meningococcal Vaccine: Which Would Spock Choose?
The topic of HPV vaccination can be a loaded one for parents. Click here for some rational data to help then face facts. (Source: ConsultantLive)
Source: ConsultantLive - August 21, 2017 Category: Internal Medicine Authors: Terry Brenneman, MD Tags: Special Report Vaccines Source Type: news

How to Pump up the Volume on Gardasil Coverage
Fingers point in all directions when the topic of low US HPV vaccination rates comes up. How to skip the drama? Just do it. (Source: ConsultantLive)
Source: ConsultantLive - August 21, 2017 Category: Internal Medicine Authors: Terry Brenneman, MD Tags: Special Report Vaccines Source Type: news

Cytology versus HPV testing for cervical cancer screening in the general population: a DTA Review from the Cochrane Gynaecological, Neuro-oncology and Orphan Cancers Group, (CGNOC)
Cochrane Reviews are systematic reviews of research in health care and policy. They are internationally recognized as a high-quality source of evidence for decision-making. They collate and summarize all the best available research evidence on the effects of healthcare interventions or the accuracy of diagnostic tests into a systematic review.Diagnostic Test Accuracy Reviews (DTA) provide essential information regarding the accuracy of the available diagnostic tools for key decision makers, including patients, clinicians, guideline developers and researchers.  The purpose of a Cochrane DTA review is very like the purp...
Source: Cochrane News and Events - August 14, 2017 Category: Information Technology Authors: mumoquit at cochrane.org Source Type: news

Class Action Lawsuit Against HPV Vaccine Filed in Colombia Class Action Lawsuit Against HPV Vaccine Filed in Colombia
An association representing 700 individuals who allege damage after receiving the human papillomavirus vaccine Gardasil has been launched in Colombia; a class action suit is ongoing in Japan.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 7, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant Sterile Suspension for Intramuscular Administratio) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 12, 2017 Category: Drugs & Pharmacology Source Type: news

Gardasil (Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 12, 2017 Category: Drugs & Pharmacology Source Type: news

Powerful new film on the HPV vaccine being released by ANH-USA
(Natural News) HPV vaccines like Cervarix and Gardasil have harmed young women and girls across the globe. And yet, many mainstream media sources, like NPR, have continued to perpetuate the myth that these vaccines are totally safe, effective and incapable of causing harm. However, more people and organizations are waking up to the reality that... (Source: NaturalNews.com)
Source: NaturalNews.com - May 12, 2017 Category: Consumer Health News Source Type: news

Gardasil strikes again: HPV vaccine is to blame for daughter's paralysis, warns mother
(Natural News) After suffering an allergic reaction to the controversial human papillomavirus (HPV) vaccine, Mia Blesky was left paralyzed from the neck down. Once a straight-A student and aspiring pop star who sang and danced, she’s now being home-schooled and given singing lessons at her bedside. The doctors say that it’s all in her head but... (Source: NaturalNews.com)
Source: NaturalNews.com - May 3, 2017 Category: Consumer Health News Source Type: news

Gardasil HPV Vaccine FAQ
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 25, 2017 Category: Journals (General) Source Type: news

Fetal Exposure to HPV Vaccine Appears Safe (FREE)
By the Editors Exposure to the quadrivalent human papillomavirus vaccine during pregnancy is not associated with adverse pregnancy outcomes, according to a New … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 30, 2017 Category: Primary Care Source Type: news

HPV vaccination during pregnancy shows no ill effects
(Reuters Health) - New evidence from a Danish nationwide study suggests that Sanofi Pasteur's quadrivalent human papillomavirus vaccine (HPV), marketed as Gardasil, is not dangerous in the unusual case when it is inadvertently given during early pregnancy. (Source: Reuters: Health)
Source: Reuters: Health - March 29, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

From aspiring pop star to paralysed in just days
Mia Blesky, 12, from Reading was given  the routine jab Gardasil - which protects against the human papilloma virus, in September. The straight A student went on to lose all sensation in her legs. (Source: the Mail online | Health)
Source: the Mail online | Health - March 27, 2017 Category: Consumer Health News Source Type: news

Countless teenage girls suffer paralysis, blood clots, brain damage and chronic pain from force-vaccination of Gardasil's HPV "shot in the dark"
(Natural News) A sexually transmitted disease called human papillomavirus (HPV) is the only form of cancer known to be contagious, but what the medical community won’t tell parents of teenagers and preteens is that HPV is easily defeated by a normal functioning immune system. Of the 120 or more different strains of HPV, only about... (Source: NaturalNews.com)
Source: NaturalNews.com - March 17, 2017 Category: Consumer Health News Source Type: news

Japan: HPV vaccine on trial for its horrifying side effects
(Natural News) Since last July, a total of 119 young girls and women in Japan have filed lawsuits against both the Japanese government and the two manufacturers of vaccines for human papillomavirus (HPV), GlaxoSmithKline PLC (GSK) and Merck Sharp & Dohme Corp. According to the suits, the companies’ respective HPV vaccines, Cervarix and Gardasil, caused... (Source: NaturalNews.com)
Source: NaturalNews.com - February 28, 2017 Category: Consumer Health News Source Type: news

Dozens of popular vaccines found to be contaminated with unexplained particles containing toxic heavy metals
(Natural News) The HPV vaccines Gardasil and Ceravix have been heavily scrutinized for their deleterious effects on young women around the globe — and the suggested age for receiving these vaccinations just keeps getting younger. Last year, in the beginning of 2016, the America College of Pediatricians (ACP) released a statement that detailed a host of... (Source: NaturalNews.com)
Source: NaturalNews.com - February 15, 2017 Category: Consumer Health News Source Type: news

American College of Pediatricians warns: HPV vaccine causes ovarian failure
(NaturalNews) A new warning has emerged about the use of Gardasil, a vaccine for the human papilloma virus (HPV). Gardasil (a four-strain HPV vaccine, or HPV4), is typically administered to both boys and girls as young as age 11 to prevent the sexually transmitted disease. Developed by Merck, Gardasil received FDA approval in 2006. The... (Source: NaturalNews.com)
Source: NaturalNews.com - January 17, 2017 Category: Consumer Health News Source Type: news

These Numbers Show Just How Safe Vaccines Are
Anti-vaccine advocate Robert F. Kennedy Jr. said that President-elect Donald Trump asked him to lead a new government commission on vaccine safety. But science on this issue is already clear; numerous studies show that vaccines are safe and effective, and that serious side effects are rare. On Jan. 10, Kennedy met with the president-elect at Trump Tower, and later told reporters about the new commission. However, the Trump administration did not confirm that such a commission was in the works. A spokesperson for Trump said only that the president-elect was “exploring the possibility of forming a committee on autism,&...
Source: Healthy Living - The Huffington Post - January 17, 2017 Category: Consumer Health News Source Type: news

These Numbers Show Just How Safe Vaccines Are
Anti-vaccine advocate Robert F. Kennedy Jr. said that President-elect Donald Trump asked him to lead a new government commission on vaccine safety. But science on this issue is already clear; numerous studies show that vaccines are safe and effective, and that serious side effects are rare. On Jan. 10, Kennedy met with the president-elect at Trump Tower, and later told reporters about the new commission. However, the Trump administration did not confirm that such a commission was in the works. A spokesperson for Trump said only that the president-elect was “exploring the possibility of forming a committee on autism,&...
Source: Science - The Huffington Post - January 17, 2017 Category: Science Source Type: news

New Gardasil 2-Dose Series: A Pair Equals 3-of-a-Kind
" My child won't be intimate before marriage, " is a common parental refrain. The CDC says, don't bet on it. Do you know the odds? (Source: ConsultantLive)
Source: ConsultantLive - December 9, 2016 Category: Internal Medicine Authors: Terry Brenneman, MD Tags: Child/Adolescent Vaccines Source Type: news

Parental Refusal of the Human Papillomavirus Vaccine Parental Refusal of the Human Papillomavirus Vaccine
A survey of parents highlights some common reasons why they may choose to defer the administration of the HPV vaccine.Journal of Pediatric Health Care (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 5, 2016 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

These 50 Washington doctors received the biggest payments from drug and device makers
French multi-national pharmaceutical company Sanofi-Aventis paid a doctor from Spokane more than $37,000 to travel to Athens and Paris in 2015. The same year, Gardasil and Singulair maker Merck Sharp& Dohme Corp. paid a doctor from Seattle almost $14,000 to travel to Australia. Sanofi and Merck together paid out nearly $1 million in Washington last year, and they're far from alone. Washington physicians received more than $48.6 million last year for travel and entertainment, consulting fees and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 28, 2016 Category: Pharmaceuticals Authors: Melissa Crowe Source Type: news

These 50 Washington doctors received the biggest payments from drug and device makers
French multi-national pharmaceutical company Sanofi-Aventis paid a doctor from Spokane more than $37,000 to travel to Athens and Paris in 2015. The same year, Gardasil and Singulair maker Merck Sharp& Dohme Corp. paid a doctor from Seattle almost $14,000 to travel to Australia. Sanofi and Merck together paid out nearly $1 million in Washington last year, and they're far from alone. Washington physicians received more than $48.6 million last year for travel and entertainment, consulting fees and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 28, 2016 Category: Biotechnology Authors: Melissa Crowe Source Type: news

Gardasil, considered the most dangerous vaccine on the market, may soon be pushed for infants
(NaturalNews) Gardasil has been the subject of controversy for many years now. In fact, it has even been regarded as one of the most dangerous vaccines on the market today. Perhaps what is most alarming about this treacherous vaccine, however, is the fact that its manufacturer, Merck... (Source: NaturalNews.com)
Source: NaturalNews.com - November 23, 2016 Category: Consumer Health News Source Type: news

Brief HPV Vaccination Messages Persuasive to Parents (FREE)
By Alain Joffe, MD, MPH Dr. Joffe is an associate editor with NEJM Journal Watch Pediatrics and Adolescent Medicine, from which this story was adapted. Full coverage is available to subscribers at the link below.Brief messages in support of the human papillomavirus vaccine might persuade parents to get their kids immunized, according to a study in Cancer … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 29, 2016 Category: Primary Care Source Type: news

Lead developer of HPV vaccine admits it's a giant, deadly scam
(NaturalNews) An expert involved in the approval process for the human papilloma virus (HPV) vaccines Gardasil and Cervarix, is speaking out about the dangers and why you shouldn't risk your child's health in getting them.Diane Harper, M.D., professor and chair of the department... (Source: NaturalNews.com)
Source: NaturalNews.com - September 29, 2016 Category: Consumer Health News Source Type: news

Danish girl falls sick after receiving HPV vaccine from doctors who lied, 'this vaccine has no side effects'
(NaturalNews) A young woman from Denmark has become one of the latest victims of the Gardasil vaccine scam after multiple doctors lied to her about its safety. As relayed by SaneVax.org, the story of Sanni Charlotte Falcke is all too familiar -- a trusted physician urged Sanni to... (Source: NaturalNews.com)
Source: NaturalNews.com - September 13, 2016 Category: Consumer Health News Source Type: news

Plague of corruption - Shocking vaccine safety news revealed
(NaturalNews) When I talk about seizures, encephalitis, cardiovascular disease or even sudden death – many people would think I'm talking about a new and deadly virus. In truth, these are the unwanted side effects that can follow the administration of the HPV vaccine, Gardasil... (Source: NaturalNews.com)
Source: NaturalNews.com - September 9, 2016 Category: Consumer Health News Source Type: news

Well: The Weekly Health Quiz: Happiness, Fracking and Fatal Music
Test your knowledge of this week ’ s health news. (Source: NYT Health)
Source: NYT Health - August 26, 2016 Category: Consumer Health News Authors: TOBY BILANOW Tags: Cervarix (Vaccine) Gardasil (Vaccine) Happiness Human Papillomavirus (HPV) Hydraulic Fracturing Infections medicine and health Musical Instruments Vegetables Featured Quizzes Source Type: news

Why Aren't More Parents Vaccinating Their Kids Against Cancer?
If there were a vaccine that could protect your 11-year-old son from getting cancer as an adult, you’d make sure he got it, right? As it turns out, this immunization exists, but a majority of young boys are not adequately protected, as journalist Jane Brody noted in The New York Times on Tuesday. The human papillomavirus vaccine ― which protects against HPV-associated cancers including throat and tongue, cervical, vaginal, vulvar, anal, and penile cancers ― is strongly recommended as cancer prevention for 11- and 12-year-old boys and girls by the U.S. Centers of Disease Control and Prevention. The bad n...
Source: Science - The Huffington Post - August 25, 2016 Category: Science Source Type: news

Why Aren't More Parents Vaccinating Their Kids Against Cancer?
If there were a vaccine that could protect your 11-year-old son from getting cancer as an adult, you’d make sure he got it, right? As it turns out, this immunization exists, but a majority of young boys are not adequately protected, as journalist Jane Brody noted in The New York Times on Tuesday. The human papillomavirus vaccine ― which protects against HPV-associated cancers including throat and tongue, cervical, vaginal, vulvar, anal, and penile cancers ― is strongly recommended as cancer prevention for 11- and 12-year-old boys and girls by the U.S. Centers of Disease Control and Prevention. The bad n...
Source: Healthy Living - The Huffington Post - August 25, 2016 Category: Consumer Health News Source Type: news

Mauritius: Mauritius Introduces Human Papillomavirus Vaccine for the Prevention of Cervical Cancer
[Government of Mauritius] The human papillomavirus (HPV) vaccination to prevent cervical cancer was launched today at a ceremony at Barkly Government School in Beau Bassin in the presence of the Minister of Health and Quality of Life, Mr Anil Gayan, the Minister of Education, Human Resources, Tertiary Education and Scientific Research, Mrs. Leela Devi Dookun-Luchoomun, and other personalities. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 19, 2016 Category: African Health Source Type: news

Parents more likely to support HPV vax requirements if states include opt-out provisions
(American Association for Cancer Research) Parents are more likely to support laws that would make the human papillomavirus vaccine mandatory for school entry if their state offers opt-out provisions, however, the study's lead author cautioned that such opt-out provisions may weaken the effectiveness of the vaccine requirements. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 19, 2016 Category: Infectious Diseases Source Type: news

Gardasil or Meningococcal Vaccine: Which Would Spock Choose?
Negative parental response to the HPV vaccine is often rooted in emotion. Our quick quiz offers you some rational data that could help parents face facts. (Source: ConsultantLive)
Source: ConsultantLive - August 11, 2016 Category: Internal Medicine Authors: Terry Brenneman, MD Tags: Vaccines Source Type: news

FDA Approves Gardasil 9 HPV Vaccine
By Stacy Simon RESOURCES: Cervical cancer resourcesHPV and cervical cancerHuman Papilloma Virus (HPV) VaccinesAmerican Cancer Society recommendations for HPV vaccine by age The US Food and Drug Administration (FDA) has approved Gardasil 9, a new vaccine for human papillomavirus (HPV). The vaccine is expected to become available in February 2015. Gardasil 9 protects against 9 types of HPV, more than the vaccines already on the market, Gardasil and Cervarix. Those vaccines protect against the 2 types of HPV that cause approximately 70% of cervical cancers. (Gardasil also protects against 2 more types that cause genital war...
Source: American Cancer Society :: News and Features - August 9, 2016 Category: Cancer & Oncology Tags: Cervical Cancer Prevention/Early Detection Source Type: news

HPV vaccination provides protection for immunocompromised children
A quadrivalent human papillomavirus vaccine provided adequate seroconversion response rates in immunocompromised children, according to Dr. C. Raina MacIntyre, MBBS, PhD, and her associates. In a clinical trial of 59 immunocompromised children aged 5-18, seroconversion rates for HPV types 6, 11,... (Source: Skin and Allergy News)
Source: Skin and Allergy News - August 9, 2016 Category: Dermatology Source Type: news

9-valent, quadrivalent HPV vaccines have comparable safety
The 9-valent human papillomavirus vaccine was well tolerated in 16-26 year olds and had a safety profile comparable to that of the quadrivalent vaccine, according to an analysis of seven phase III... (Source: Pediatric News)
Source: Pediatric News - July 15, 2016 Category: Journals (General) Source Type: news

Big Pharma eyes Bay Area, Boston expansions as it cuts R&D elsewhere
Drug giant Merck & Co. Inc. will cut research jobs at three East Coast sites as it searches for a major Bay Area home to consolidate its cancer and biologics R&D work and hires about 100 scientists. The company (NYSE: MRK) will move into an interim facility in South San Francisco early next year, according to a spokeswoman for the Kenilworth. N.J.-based maker of the Gardasil human papillomavirus vaccine, cancer immunotherapy drug Keytruda and a host of other products. But it is continuing a search… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 13, 2016 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Big Pharma eyes Bay Area, Boston expansions as it cuts R&D elsewhere
Drug giant Merck & Co. Inc. will cut research jobs at three East Coast sites as it searches for a major Bay Area home to consolidate its cancer and biologics R&D work and hires about 100 scientists. The company (NYSE: MRK) will move into an interim facility in South San Francisco early next year, according to a spokeswoman for the Kenilworth. N.J.-based maker of the Gardasil human papillomavirus vaccine, cancer immunotherapy drug Keytruda and a host of other products. But it is continuing a search… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 13, 2016 Category: Biotechnology Authors: Ron Leuty Source Type: news

Big Pharma eyes Bay Area, Boston expansions as it cuts R&D elsewhere
Drug giant Merck & Co. Inc. will cut research jobs at three East Coast sites as it searches for a major Bay Area home to consolidate its cancer and biologics R&D work and hire about 100 scientists. The company (NYSE: MRK) will move into an interim facility in South San Francisco early next year, according to a spokeswoman for the Kenilworth. N.J.-based maker of the Gardasil human papillomavirus vaccine, cancer immunotherapy drug Keytruda and a host of other products. But it is continuing a search… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 12, 2016 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Big Pharma eyes Bay Area, Boston expansions as it cuts R&D elsewhere
Drug giant Merck & Co. Inc. will cut research jobs at three East Coast sites as it searches for a major Bay Area home to consolidate its cancer and biologics R&D work and hire about 100 scientists. The company (NYSE: MRK) will move into an interim facility in South San Francisco early next year, according to a spokeswoman for the Kenilworth. N.J.-based maker of the Gardasil human papillomavirus vaccine, cancer immunotherapy drug Keytruda and a host of other products. But it is continuing a search… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 12, 2016 Category: Biotechnology Authors: Ron Leuty Source Type: news

Reduced HPV Vaccine Dosing Could Be WorthwhileReduced HPV Vaccine Dosing Could Be Worthwhile
The US Food and Drug Administration recommends three doses of the human papillomavirus vaccine (HPV), but recent data suggest that fewer shots might be sufficient. Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 24, 2016 Category: Allergy & Immunology Tags: Nursing News Source Type: news

Systematic Review of 58 Publications of Real-World Use of GARDASIL® Presented at EUROGIN Congress
Dateline City: KENILWORTH, N.J. Studies Published over the Last 10 Years Report Reductions in Cervical Pre-cancers and Other HPV-related Diseases KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced today that in a systematic review conducted of the global impact and effectiveness of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], substantial reductions were observed in HPV 6/11/16/18-related infection, genital warts, Pa...
Source: Merck.com - Corporate News - June 16, 2016 Category: Pharmaceuticals Tags: Vaccine News Corporate News Latest News #Merck #MRK $MRK EUROGIN Gardasil MSD NYSE:MRK Source Type: news

Systematic Review of 58 Publications of Real-World Use of GARDASIL ® Presented at EUROGIN Congress
Dateline City: KENILWORTH, N.J. Studies Published over the Last 10 Years Report Reductions in Cervical Pre-cancers and Other HPV-related Diseases KENILWORTH, N.J.--( BUSINESS WIRE )--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced today that in a systematic review conducted of the global impact and effectiveness of GARDASIL ® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], substantial reductions were observed in HPV 6/11/16/18-related infection, genital warts, Pap abnormalities and cervical pre-cancers. La...
Source: Merck.com - Corporate News - June 16, 2016 Category: Pharmaceuticals Tags: Vaccine News Corporate News Latest News #Merck #MRK $MRK EUROGIN Gardasil MSD NYSE:MRK Source Type: news

Irish teen girls taking on Gardasil manufacturers after suffering from long-term injuries caused by the faulty vaccines
(NaturalNews) Teen girls and their mothers in Ireland are setting an example for how to build an influential movement to fight back against a mainstream vaccine consensus that pushes the dangerous human papillomavirus (HPV) vaccine on girls as young as eleven.The support group... (Source: NaturalNews.com)
Source: NaturalNews.com - May 24, 2016 Category: Consumer Health News Source Type: news

HPV vaccine makers to be sued in Japan for damage and deaths caused by toxic immunizations
(NaturalNews) In response to vaccine injuries linked to the HPV vaccines Gardasil and Cervarix, 12 plaintiffs in Japan plan to file a class action lawsuit against the Japanese government, Merck and GlaxoSmithKine after June 2016. The plaintiffs are seeking answers about why they were... (Source: NaturalNews.com)
Source: NaturalNews.com - April 19, 2016 Category: Consumer Health News Source Type: news